Long-term outcome of chronic hepatitis B in adolescents or young adults in follow-up from childhood

Journal of Pediatric Gastroenterology and Nutrition

Volumn 30, Issue 2, 2000, Pages 201-206

  Fujisawa, Tomoo ^a   Komatsu, Haruki ^a   Inui, Ayano ^a   Sogo, Tsuyoshi ^b   Miyagawa, Yoshihiro ^a   Fujitsuka, Satoshi ^a   Sekine, Isao ^b   Kosugi, Takeshi ^c   Inui, Michio ^c  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Kanto Teishin Hospital   (Japan)

^c Koutoh Hospital   (Japan)

Author keywords

Children; Chronic hepatitis B; Hepatocellular carcinoma; Interferon

Indexed keywords

ALPHA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ARTICLE; CHILD; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS B; HUMAN; INFANT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEROCONVERSION; TREATMENT OUTCOME;

ADOLESCENT; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; FOLLOW-UP STUDIES; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON TYPE II; LIVER NEOPLASMS; LONGITUDINAL STUDIES; TREATMENT OUTCOME;

HEPATITIS B VIRUS;

EID: 0034124826     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200002000-00019     Document Type: Article

References (24)

1. Bortolotti F, Cadrobbi P, Crivellaro C, et al. G. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990;99:805-10.
2. Bortolotti F, Jara P, Crivellaro C, et al. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998;29:184-90.
3. Ruiz-Moreno M, Camps T, Aguado JG, et al. Serological and histological follow up of chronic hepatitis B infection. Arch Dis Child 1989;64:1165-9.
4. Ruiz-Moreno M, Otero M, Millan A, et al. Clinical and histological outcome after hepatitis B e antigen to antibody seroconversion in children with chronic hepatitis B. Hepatology 1999;29:572-5.
5. Chang MH, Hsu HY, Hsu HC, Ni YH, Chen JS, Chen DS. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: With special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 1995;22:1387-92.
6. Lok AS, Lai CL. A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children. Hepatology 1988; 8:1130-3.
7. Kaplan PM, Gerin JL, Alter HJ. Hepatitis B-specific DNA polymerase activity during post-transfusion hepatitis. Nature 1974;249: 762-4.
8. Inui A, Fujisawa T, Komatsu H. Rapid detection of hepatitis C virus by direct reverse transcription-polymerase chain reaction. Int Hepatol Commun 1995;3:126-30.
9. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer JP. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-20.
10. Korenman J, Baker B, Waggoner J, Everhart JE, Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629-34.
11. Bortolotti F, Wirth S, Crivellaro C, Alberti A, Martine U, de Moliner L. Long term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion. J Pediatr Gastroenterol Nutr 1996;23:270-4.
12. Niederau C, Heintges T, Lange S, et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996;334:1422-27.
13. Sokal EM, Conjeevaram HS, Roberts EA, et al. Interferon alfa therapy for chronic hepatitis B in children: A multinational randomized controlled trial. Gastroenterology 1998;114:988-95.
14. Lai CL, Lok AS, Lin HJ, Wu PC, Yeoh EK, Yeung CY. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children. Lancet 1987;2(8564):877-80.
15. Ruiz-Moreno M, Jimenes J, Porres JC, Bartolome J, Moreno A, Carreno V. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B. Digestion 1990;45: 26-33.
16. Lok AS. Alpha-interferon therapy for chronic hepatitis B virus infection in children and Oriental patients. Gastroenterol Hepatol 1991;6(Suppl)1:15-17.
17. Giacchino R, Main J, Timitilli A, et al. Dual-center, double-blind, randomized trial of lymphoblastoid interferon alpha with or without steroid pretreatment in children with chronic hepatitis B. Liver 1995;15:143-8.
18. Narkewicz MR, Smith D, Silverman A, Vierling J, Sokol RJ. Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment. J Pediatr 1995;127:815-8.
19. Torre D, Tambini R. Interferon-alpha therapy for chronic hepatitis B in children: A meta-analysis. Clin Infect Dis 1996;23:131-7.
20. Vajro P, Migliaro F, Fontanella A, Orso G. Interferon: A meta-analysis of published studies in pediatric chronic hepatitis B. Acta Gastroenterol Belg 1998;61:219-23.
21. Baffauff A, Schneider T, Gerner P, Habermehl P, Beherens R, Wirth S. Safety and efficacy of interferon retreatment in children with chronic hepatitis B. Eur J Pediatr 1998;157:382-5.
22. Iorio R, Penstai P, Botta S, et al. Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 1997;16:984-90.
23. Brook MG, Main J, Yap I, et al. Short report: Prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection. Aliment Pharmacol Ther 1993;7:331-6.
24. Lin SM, Sheen IS, Chien RN, Chu CM, Liaw YF. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection. Hepatology 1999;29:971-5,